Tag: #M&A

Swedish biotech AlzeCure Pharma has announced that it has entered into a definitive collaboration and global out-licensing agreement with Eli... Read more

British drugmaker GSK has entered into a definitive agreement to acquire US-listed lung cancer biotechnology firm Nuvalent for an aggregate... Read more

Roche has officially announced that it has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics, Inc.. Under... Read more

Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a biotechnology... Read more

Gilead Sciences Inc. and Lakefront Biotherapeutics NV have formally finalized the acquisition of Ouro Medicines to accelerate innovative T cell... Read more

U.S. pharmaceutical major Eli Lilly and Co. has entered into a definitive global licensing agreement with biotechnology firm Ascidian Therapeutics... Read more

Public equity markets logged a significant upward move for biotech developer Rallybio Corp., with its stock price hitting 24-month trading... Read more

U.S. pharmaceutical powerhouse Eli Lilly and Company and South Korea’s Hanmi Pharm have formalized a definitive licensing and commercialization agreement... Read more

U.S. biotech developer Edgewise Therapeutics has entered into a definitive agreement to sell its muscular dystrophy drug candidate and related... Read more